Article

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for…

medRxiv · 2020 · Brian L. Le, author Gaia Andreoletti, author Tomiko Oskotsky, author Albert Vallejo-Gracia, author Romel Rosales, author Katharine Yu, author Idit Kosti, author Kristoffer E. Leon, author Daniel G. Bunis, author Christine Li, author G. Renuka Kumar, author Kris M. White, author Adolfo García-Sastre, author Melanie Ott, author Marina Sirota, author

Key facts

Title Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
First author Brian L. Le, author Gaia Andreoletti, author Tomiko Oskotsky, author Albert Vallejo-Gracia, author Romel Rosales, author Katharine Yu, author Idit Kosti, author Kristoffer E. Leon, author Daniel G. Bunis, author Christine Li, author G. Renuka Kumar, author Kris M. White, author Adolfo García-Sastre, author Melanie Ott, author Marina Sirota, author
Journal medRxiv
Published Oct 25, 2020
DOI 10.1101/2020.10.23.352666
Devices mentioned BK110039, DEN000008, K022086
Product codes mentioned JCI, KIT, NDS, NJT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature